- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Philips installs 3-tesla MRI
The first Intera very high field scanner has been installed at the Institute of Biomedical Engineering, University and ETH in Zùrich, Switzerland. The institute has served as a key luminary site for Philips Medical Systems, having developed the
The first Intera very high field scanner has been installed at the Institute of Biomedical Engineering, University and ETH in Zùrich, Switzerland. The institute has served as a key luminary site for Philips Medical Systems, having developed the earliest version of the company’s Sensitivity Encoding (SENSE) technology. The potential of this technique and others will be explored on the 3-tesla product. Key projects will be investigations of epilepsy and the metabolism of glutathione and its role in psychiatric diseases. The higher signal-to-noise potential and scanning speeds possible on the 3-tesla system will allow studies of cardiac function and enhanced coronary MRA. Spectroscopic analyses of phosphorous metabolites such as ATP and phosphorous creatine will be used to examine cardiac contractility. The 3-tesla installation comes less than a year after Philips revealed plans to develop the product, which is designed for routine clinical as well as research scanning. The new product, along with an Intera 1.5-tesla scanner, will serve as the nucleus of a major MR research and competence center scheduled to open at the institute in the third quarter of this year.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
